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ABSTRACT 




April 18, 2013 
 
Tobacco-related chronic lung diseases are characterized by alterations in lung 
architecture, leading to decreased lung function and airflow limitation. Knowledge of the 
exact mechanisms involved in tobacco-induced tissue remodeling and inflammation 
remains incomplete. We hypothesized that nicotine, a component of tobacco, stimulates 
the expression of extracellular matrices leading to relative changes in lung matrix 
composition, which may affect immune cells entering the lung during inflammation. We 
found that nicotine stimulated collagen type I mRNA and protein expression in a dose- 
and time-dependent manner in primary lung fibroblasts. The stimulatory effect of 
nicotine was inhibited in lung fibroblasts harvested from mice with α7 nicotinic 
acetylcholine receptor (nAChR) knockout mutations. Testing the potential role of these 
events on immune cell function, U937 monocytic cells, expressing the interleukin-1β (IL-
1β) gene promoter fused to a reporter gene, were cultured atop extracellular matrices 
derived from nicotine-treated lung fibroblasts. These cells expressed more IL-1β than 
those cultured atop matrices derived from untreated fibroblasts, and antibodies against 
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a collagen receptor, α2β1 integrin receptor, inhibited the effect. Nicotine-stimulated 
fibroblast proliferation via MEK-1/Erk, unveiling a potentially amplifying pathway. In 
vivo, nicotine increased the presence of collagen type I in the lung, primarily around the 
airways. These observations suggest that nicotine stimulates fibroblast proliferation and 
their expression of collagen type I, thereby altering the relative composition of the lung 
matrix without impacting the overall lung architecture; this ‘transitional remodeling’ may 
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PREFACE 
  The human lung is constantly exposed to a wide range of harmful particles and 
compounds in the air. To handle this constant challenge, the lung is a very dynamic 
organ, readily repairing itself against a range of antigens and environmental pathogens. 
Correct lung repair allows for normal lung function, but disrepair can lead to difficult to 
treat diseases like Chronic Obstructive Pulmonary Diseases (COPDs). Tobacco exposure 
is associated with increased risk for the development of COPDs, like emphysema and 
chronic bronchitis, and is the main cause of lung cancer globally, leading us to investigate 
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INTRODUCTION 
With more than 20% of the world reported to be smokers, tobacco is considered 
to be a major cause of lung cancer, killing over 6 million individuals in 2011 alone. 
Secondhand smoke exposure is an additional concern, killing an estimated 600,000 
people annually, mostly women and children [2]. While the health effects of tobacco on 
exposed individuals are well recognized, the financial effects are often overlooked. 
Smoking is estimated to cost the American economy over $193 billion annually [3]. 
Moreover, tobacco smoke is extremely complex, containing more than 4000 chemicals, 
which have been found to interact with a multitude of molecules and pathways (MEK-
1/Erk, Smad), preventing the effective and safe targeting of a single mechanism of action 
with significant therapeutic benefit. A larger effect of tobacco smoke is the induction of 
inflammation, a process characterized by the release of soluble mediators, oxidant stress, 
and the recruitment of inflammatory cells into tissue [4]. Inflammation is thought to 
promote tissue remodeling, leading to alterations in lung structure and function, and 
promote oncogenesis [5]. 
Nicotine, a potent and highly addictive parasympathetic alkaloid, is a primary 
component of tobacco smoke and represents ~0.6–3.0% of the dry weight of tobacco 
leaves [6]. Once nicotine enters the brain, it elevates mood and arousal, and reinforces 
avoidance of withdrawal comparable to that of cocaine and heroin in addictiveness [7]. 
When inhaled, nicotine is easily absorbed through the buccal mucosa and cutaneous 
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membranes, with approximately 25% of nicotine diffusible across the alveolar membrane 
at physiological pH. Additionally, nicotine is stored within the lung for a short time 
before entering the bloodstream. Thus, the lungs also serve as nicotine reservoirs, such 
that pulmonary tissue has shown four times higher concentrations than the brain after 
ventricular injection [8].  
Recent studies have unveiled the existence of nicotinic receptors capable of signal 
transduction in lung tissue [9], which was shown to correlate with effects on lung 
development [10, 11] and inflammatory processes [12]. NAChRs comprise a family of 
multimeric acetylcholine-triggered cation channel proteins that form the predominant 
excitatory neurotransmitter receptors on muscles and nerves within the peripheral 
nervous system. They are also expressed in lower amounts throughout the central nervous 
system [13, 14]. The binding of a ligand such as acetylcholine (endogenous) or nicotine 
(exogenous) to nAChRs leads to a depolarization of the membrane and the generation of 
an action potential that spreads along the surface of the postsynaptic cell membrane. The 
initial depolarization is the result of Na+/K+ channels opening, which subsequently 
causes voltage gated calcium channels to open allowing an influx of calcium, an 
important cation responsible for eliciting a number of signaling events [15, 16]. This 
depolarization leads to the activation of poorly understood downstream events, including 
the accumulation of cAMP and the induction of mitogen activated protein kinases [17].  
In each of these receptors, the various subunits assemble into pentamers in a 
homomeric or heteromeric fashion. α3, α5, and α7 nAChR subunits are expressed on the 
surface of lung fibroblasts, epithelial cells, endothelial cells, and alveolar macrophages, 
and have been implicated in both the regulation of inflammation and cancer [18, 19]. At 
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least thirteen genes that code for nAChR subunits have been identified to date: 4 β 
subunits and 9 α subunits [20]. The α7 nAChR is the most abundant homopentamer, 
consisting of 5 α7 subunits, and is highly selective for calcium influx. In developing 
primate lungs, α7 nAChRs were detected within airway epithelial cells, around large 
airways and blood vessels, free alveolar macrophages, alveolar type II cells, and 
pulmonary neuroendocrine cells [10]. Additionally, α7 nAChR expression is increased 
with nicotine administration in bronchial epithelial and endothelial cells, as well as in 
non-small cell lung carcinoma cells [21, 22]. This upregulation of nAChRs in the brain is 
one mechanism believed to drive nicotine addiction.  
Our laboratory has conducted work with murine primary lung fibroblasts, which 
are the main cells for synthesizing connective lung tissue. We demonstrated that nicotine 
stimulates lung fibroblasts to express fibronectin by acting on α7 nAChRs, both in vitro 
and in vivo [23]. Fibronectin is a matrix glycoprotein, which is highly expressed in 
injured tissues, and is considered a sensitive marker of tissue injury and activation of 
tissue remodeling [24, 25]. In the injured lung, fibronectin is deposited over denuded 
basement membranes where it is thought to support the migration of alveolar epithelial 
cells during repair [25]. The excessive deposition of fibronectin, however, has been 
hypothesized to promote disrepair [26]. Human studies also show increased fibronectin 
content within the bronchoalveolar lavage fluid of smokers [27]. The role of nicotine in 
pulmonary remodeling and the pathways by which it could cause these changes are not 
yet defined. 
In this study, we extend our work to investigate additional extracellular matrix 
modifications via nicotine exposure. We show that nicotine stimulates lung fibroblasts to 
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express collagen type I. This fibrillar collagen is another matrix component highly 
expressed in tissues during injury and repair, and its expression signals activation of 
tissue remodeling. Collagen type I is the most common form of collagen in the human 
body and is highly abundant within connective tissue, including tendon, ligament, skin, 
and lung tissue. Each rope-like procollagen molecule is made up of three chains: two pro-
α1 (I) chains, which are produced from the COL1A1 gene, and one pro-α2 (I) chain, 
which is produced from the COL1A2 gene. After processing, the resulting mature 
collagen molecules arrange themselves into long, thin fibrils. Individual collagen 
molecules are then cross-linked to one another within these fibrils, thereby forming 
strong collagen fibrils [28].  
Studies performed in vivo confirmed nicotine induction of collagen type I, in the 
absence of changes in overall architecture of the lung matrix. Also, using fibroblast-
derived matrices, we have shown that excess collagen deposition may help activate 
resident and incoming monocytic cells and stimulate their expression of pro-
inflammatory cytokines. Together, these observations suggest that nicotine stimulates 
alterations in the relative composition of the lung matrix favoring collagen type I 
expression without altering the overall tissue architecture of the lung [Figure 1]. These 
subtle changes, termed ‘transitional remodeling’, may render the host susceptible to 









Figure 1: Nicotine promotes a Transitional Matrix through α7 nAChRs 
We hypothesized that nicotine, a component of tobacco, stimulates the expression of 
extracellular matrices leading to relative changes in lung matrix composition, which may 
































Figure 2: Nicotine-induced Transitional Matrix Promotes Lung Disrepair 
Previous studies suggest that nicotine stimulates subclinical alterations in the relative 
composition of the lung matrix, favoring fibronectin [23] and collagen type I (this report) 
expression. These subtle changes, termed transitional remodeling, may render the host 
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MATERIALS AND METHODS 
Reagents 
The mitogen-enhanced kinase-1 (MEK-1) inhibitor PD98059 was purchased from 
New England Biolabs, Inc. (Beverly, MA) and the α7 antagonist, MG-264, was 
purchased from Santa Cruz (Dallas, TX). Trypsin 10x was purchased from Corning 
Cellgro (Manassas, VA) and diluted to 2.5X with dH20. Mouse α7 nAChR siRNA, and 
control non-target siRNAs and Real-Time Quantitative PCR primers (QuantiTect Primer 
Assays) used to quantify mRNA levels by Real-Time RT-PCR were purchased from 
Qiagen (Valencia, CA). All other reagents were purchased from Sigma Chemical 
Company (St. Louis, MO) or Fisher Scientific (Pittsburgh, PA) unless otherwise 
specified.  
 
Cell Culture and Treatment 
Primary lung fibroblasts (between 3-8 passages) were harvested from wild type 
control C57BL/6 or α7 nAChR deficient C57BL/6 mice (Jackson Laboratories, Bay 
Harbor, MA) and cultured in Dulbecco's Modified Eagle Medium (DMEM; Corning 
Cellgro), as previously described [23, 29]. Cells were grown in Heracell 150 incubators 
(Thermo Scientific, Waltham, MA) at 37°C and 5% CO2. The lack of α7 nAChRs in 
knock-out mice was verified by RT-PCR and Western Blot (Figure 4A). 
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The dose of nicotine (1-75 µg/ml) used was chosen based on previous 
experiments in the lab and published literature [23]. U937, human monocytic cells 
permanently transfected with human Il-1β gene promoter connected to a luciferase 
reporter gene were cultured in 400ug/ml HyClone geneticin G418 (Thermo Scientific) in 
RPMI 1640 (Corning Cellgro). All media was supplemented with 10% fetal bovine 
serum (Atlanta Biologicals, Lawrenceburg, GA) and 1% Antibiotic Antimitotic Solution 
(Corning Cellgro). Cell viability was determined by Trypan Blue exclusion.  
 
Silencing of nAChRs and Detection of mRNAs by Reverse-Transcriptase 
Polymerase Chain Reaction 
Primary lung fibroblasts were plated onto 12-well plates (4 x 104 cells/well) and 
cultured for 24 hours. Fibroblasts were transfected with α7 nAChR or control non-target 
siRNA (150 ng) according to manufacturer’s protocol using HiPerFect Transfection 
Reagent (Qiagen). Silencing of α7 nAChR was also confirmed by Western blot. 
Transfected or control fibroblasts were then treated with 50 µg/ml nicotine for up to 72 
hours. Media was aspirated and replaced with PBS. Cells were lifted from wells with cell 
scrapers (Corning) and centrifuged (550 x g for 5 minutes). PBS was aspirated then 400-
500 µL of RNAzol B™ (Tel-test Inc., Friendswood, TX) was added to the harvested cells 
and vortexed. Chloroform-isoamyl alcohol (400 µl) was added, vortexed, and placed on 
ice for 15 minutes. Samples were spun at 4oC for 15 minutes at 17,500 x g. RNA was 
transferred to a new microfuge tube and 500 µL cold isopropanol was added, mixed, and 
incubated on ice for 15-30 minutes. Samples were spun at 4oC for 15 minutes at 17,500 x 
g, and pellet washed with 95% EtOH and then 70% EtOH. RNA pellets were 
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resuspended in 100 µL of RNAse free H2O with 1 mM EDTA. RNA concentrations were 
determined by OD260 x dilution factor x 40 = ng/µl in crystal cuvettes using a GS-800 
Calibrated Densitometer (Bio-rad). 
RT-PCR was performed as previously described [30] utilizing the following 
primers: mouse collagen type I forward (5’-GTGCTGTTGGTGCTGCTG), reverse (5’-
CAGGAGCACCAGCAATAC); 18S forward (5’-GTGACCAGAGCGAAAGCA), 
reverse (5’-ACCCACGGAATCGAGAAA); α7 nAChR forward (5’-
CTGCTGGGAAATCCTAGGCACACTTGAG or GACAAGACCGGCTTCCATCC), 
reverse (5’-CCTGGTCCTGCTGTGTTAAACTGCTTC); or IL-1β forward (5’- 
ACACATGGGATAACGAGG), reverse (5’- GCTGTAGAGTGGGCTTAT) in a Labnet 
Multigene Gradient thermocycler (Edison, NJ) for PCR and Cepheid SmartCycler 
(Cepheid, Sunnydale, CA) for real-time PCR. Negative controls consisted of dH2O and 
RNA without PCR agents. Gel pictures were taken with Biodoc Imagining System (UVP, 
Upland, CA). Values were normalized to 18S and expressed as relative change vs. 
untreated mouse lung tissue. 
 
Protein Detection via Western Blotting 
Western blots were performed as previously described [23, 29]. Samples were 
isolated using western homogenization buffer (50 mM NaCl, 50 mM NaF, 50 mM 
NaP2O7-10 H2O, 5 mM EDTA, 5 mM EGTA, 2 mM Na3VO4,  0.5 mM PMSF, 0.01% 
Triton X-100, 10 µg/ml leupeptin, 10 mM HEPES, pH 7.4), and sonocated for 5 seconds 
using Sonifier 450 (Branson, Danbury, CT). Protein concentrations were determined 
using Bradford reagent (Sigma) standard curve readings in DU-800 Spectrophotometer 
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(Beckman Coulter, Brea, CA). Gels were either 10% (denaturing) or 5% (native) 
acrylamide gels (Bio-rad, Hercules, CA) run in a mini trans-blot system (Bio-rad). Non-
collagen samples were heated to 95oC for 5 minutes and spun for 10 minutes at 17,500 x 
g. Gels were run for 2 hours at 125 volts using a Powerpack HC power supply (Bio-rad).  
Protein was transferred to Protran Nitrocellulose transfer membrane (Whatman), 
between 4 pieces of extra thick western blotting filter paper (Thermo Scientific), soaked 
in Pierce Western Blot Transfer Buffer (Thermo Scientific), then transferred for 2 hours 
at 25 volts in Trans-Blot SD semi-dry transfer cell (Bio-rad). Membranes were agitated in 
wash buffer (3 x 10 minutes) and then incubated in 5% Bovine Serum Albumin or 5% 
non-dry fat milk blocking buffer for 1 hour. Blots were incubated with primary 
polyclonal antibody against either GAPDH (Sigma; 1:1000 dilution), collagen type I 
(Sigma; 1:1000; denatured, reduced gel) or (Abcam, Cambridge, MA; 1:10000; native, 
non reducing gel), p-Smad3 (Rockland Immunochemicals, Gilbertsville, PA; 1:2000), p-
Erk 1&2 (Cell Signaling, Beverly, MA; 1:1000), total Smad3 (Upstate Cell Signaling, 
Lake Placid, NY; 1:1000), total Erk (Cell Signaling; 1:1000), and α7 nAChR (Sigma; 
1:500) overnight at 4oC. Membranes were agitated in wash buffer (3 x 10 minutes) before 
incubation in 2o antibody goat anti-rabbit IgG (Sigma; 1:20,000) for 1 hour at room 
temperature. Membranes were agitated in wash buffer (3 x 10 minutes) and then 
incubated with Amersham ECL Western Blotting Detection Reagents (GE Healthcare, 
Little Chalfont, UK) for 5 minutes and exposed to Genemate Blue Basic Autorad film 
(Bioexpress, Kaysville, UT) for up to 1 hour. Protein densitometry was completed using 
GS-800 Calibrated Densitometer (Bio-rad).  
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Cell Viability Assay   
Wild type or transfected primary lung fibroblasts (1 x 104 cells/ml) were added to 
96-well tissue culture plates and incubated at 37oC for 24 hours in COMPLETE™ 
Serum-Free/Low-Protein Medium (Corning Cellgro), then for up to 72 hours with 
nicotine (50 µg/ml) in the presence or absence of the MEK1 inhibitor, PD98059 (50 µM). 
Afterwards, the luminescence of viable cells was detected using Cell Titer-Glo 
Luminescent Cell Viability Assay Kit (Promega) in a Luminoskan Ascent Luminometer 
(Beckman Coulter) according to the manufacturer’s instructions.  
 
Matrix Deposition and IL-1β  Measurement 
Fibroblasts were cultured for 24 hours then treated with nicotine (50 µg/ml), 
ethanol  (60 mM), N-acetylcysteine (NAC)(5 mM), PD98059 (50 µM), and/or MG-264 
(10 µM) in DMEM (Cellgro) and retained in culture in 6 well Costar Cell Culture plates 
(Corning) for 120 hours. Afterwards, the fibroblasts were eliminated by osmotic lysis. 
Cells were washed once with PBS containing 1 mM EDTA (3A solution), then treated for 
30 minutes at 4°C with the 3B solution (0.25 M NH4OH, 1 mM EDTA, 1 mM PMSF). 
The cells were washed 2 additional times with solution 3A, and then treated for 15 
minutes at 4°C with solution 3E (1 M NaCl in 50 mM Tris (pH 7.4), 1 mM EDTA, 1 mM 
PMSF). Lastly, the culture plates were washed once with solution 3A. Isolated matrices 
were stored at 4°C with PBS. 
Human monocytic U937 cells permanently transfected with the human IL-1β 
gene promoter fused to a luciferase reporter gene [31] were incubated in RPMI (Cellgro) 
on matrix-coated plates for 24 hours. Inhibition was achieved by pre-treatment of mouse 
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IgG (1:100; Sigma) or anti-α2β1 integrin (1:100; Abcam) antibody for 1 hour followed 
by culturing with the matrix-coated plates 24 hours. Afterwards, the luminescence of 




Wildtype or α7 nAChR deficient C57BL/6 (female, 8-12 weeks; Jackson 
Laboratories) were housed on a 12-hour light cycle in a pathogen-free barrier facility 
accredited by the Association for Assessment and Accreditation of Laboratory Animal 
Care. C57BL/6 mice were fed a normal diet and exposed to untreated or nicotine-treated 
(100 µg/ml) tap water ad libitum for 90 days. Mice were euthanized by exsanguination 
followed by en bloc isolation of the lungs which were inflated at standard pressure, fixed 
in formalin, paraffin-embedded, and sectioned (5 µm) using JUNG RM2055 microtome 
(Leica, Buffalo Groce, IL), then transferred onto Colorfrost microslides (VWR Sciences, 
Radnor, PA) for histological analysis. The University of Louisville’s Institutional Animal 
Care and Use Committee approved all animal studies. 
 
Histological Analysis 
Lung sections were stained using Weigert's iron hematoxylin for 10 minutes, 
rinsed in dH20, then treated with Biebrich scarlet-acid fuchsin solution for 10 minutes. 
The slides were washed in dH20, then transferred to aniline blue stain for 30-60 minutes 
(Masson Tri-chrome Staining Kit, Richard-Allan Scientific, Kalamazoo, MI). For Sirius 
Red/Fast Green staining, slides were treated with 5% Sirius Red (Polysciences Inc, 
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Warrington, PA) and then were Fast Green (Achros New Jersey) saturated with picric 
acid for 30 minutes each. Lung microscopy pictures were taken with XL Core EVOS 
microscope (Life Technologies, Carlsbad, CA). The tri-chrome slides were blindly 
graded on their intensity of collagen staining by 6 investigators based on a provided 
rubric of 0-3 (0 = no fibrosis, 1 = 1-33% of field affected by fibrosis, 2 = 33-66% of field 
affected, and 3 = 66-100% of field affected) (Figure 9).  
 
Statistical Evaluation 
All experiments were repeated using at least 3 samples. Means plus the standard 
deviation of the means were calculated for all experimental values after normal 
distribution was verified. Significance was assessed by p-values <0.05, which were 
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RESULTS 
Nicotine stimulates the expression of collagen type I  
 The goal of this study was to further explore the effects of nicotine on pulmonary 
cells and their extracellular matrices. We found that nicotine stimulated the expression of 
collagen type I in lung fibroblasts. Nicotine stimulated collagen type I mRNA and protein 
expression in a time-dependent fashion with a maximum effect noted at 72 hours  (Figure 
3A and B). Nicotine also stimulated a dose-dependent collagen expression, with a 
maximum mRNA expression increase occurring in cells exposed to 25-50 µg/ml of 
nicotine (Figure 3C). Additionally, nicotine exposure stimulated collagen type I protein 
production in both cell extracts and supernatants (Figure 3D).  
 
Role of α7 nAChRs  
 The lack of α7 nAChRs in α7 nAChR deficient mice was verified by PCR and 
Western blotting (Figure 4A). Real-time RT-PCR showed that α7 nAChR mRNA 
expression in whole lung homogenates of nicotine-treated mice was elevated but not 
significant when compared to untreated mice (Figure 4B). We then evaluated collagen 
type I protein expression in primary lung fibroblasts harvested from wildtype and α7 
nAChR deficient animals. Nicotine (50 µg/ml for 24 hours) stimulated collagen type I 
protein expression in wildtype cells, as demonstrated by Western blot analysis, 
however,this stimulation was greatly reduced in α7 nAChR KO cells (Figure 4C). 




Figure 3: Nicotine Stimulates Collagen Type I mRNA and Protein Expression  
(A and B) Nicotine stimulated collagen type I mRNA and protein expression in a time-
dependent fashion, with a maximum effect noted at 72 h (C and D). Nicotine induced the 
expression of collagen type I mRNA and protein in a dose-dependent fashion. Maximum 
increase in mRNA expression was observed at 25-50 µg/ml of nicotine. After nicotine 
stimulation, collagen type I protein was detected in both cell extracts (native gel) and 
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Figure 4: Nicotine acts through α7 nAChRs 
(A) The absence of α7 nAChR was verified by mRNA and protein expression in α7 
nAChR KO mice. (B) Total Lung RNA of mice exposed to nicotine (100 µg/ml in the 
drinking water for 90 days) were analyzed for α7 nAChR expression by RT-PCR after 
nicotine exposure, but not found to be statistically significant when compared to controls. 
(C) A significant increase in collagen type I protein expression, over control, was 
detected in nicotine-treated primary lung fibroblasts (PLF) by Western blot. However, 
nicotine did not stimulate collagen expression in α7 nAChR KO fibroblasts. Experiments 
were repeated at least 3 times. Significance was assessed using p-values <0.05 obtained 
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Extracellular matrices derived from nicotine-treated lung fibroblasts stimulate 
monocytic cell expression of interleukin-1β  
Having shown that nicotine stimulates collagen type I expression by acting on α7 
nAChRs, we investigated whether matrices derived from nicotine-treated fibroblasts exert 
a differential effect on immune cells. For this, we cultured U937 human monocytic cells 
expressing the human interleukin-1β (IL-1β) gene promoter fused to a luciferase reporter 
gene atop of extracellular matrices derived from untreated or nicotine-treated fibroblasts 
[31]. As presented in Figure 5A, we found that IL-1β gene transcription was increased in 
U937 cells cultured atop of matrices derived from nicotine-treated fibroblasts when 
compared to cells cultured atop matrices derived from untreated fibroblasts. The presence 
of an anti-oxidant N-acetylcysteine (NAC) significantly reduced the IL-1β transcription 
by half. U937 monocytes without matrices showed no difference in reactivity when 
compared to untreated matrices. This effect appeared to be mediated by collagen binding 
to α2β1 integrin receptor, which interacts with collagen in the ECM, since anti-α2β1 
subunit antibodies inhibited the induction of IL-1β (Figure 5B). Nicotine-cultured 
fibroblast matrix IL-1β induction was inhibited by α7 nAChR antagonist MG-624 (10 
µM) without affecting baseline expression (Figure 6A). Additionally, IL-1β induction 
was inhibited by MEK-1 inhibitor PD98059 (50 µM), which brought IL-1β expression 
below baseline (Figure 6B). Importantly, IL-1β gene transcription was not increased in 
U937 cells cultured atop matrices derived from nicotine-treated α7 nAChR deficient 
primary lung fibroblasts over control (Figure 6C). Nicotine-treated and untreated 
C57BL/6 whole lung IL-1β gene transcription was examined by Real-time RT-PCR. 
Nicotine-treated lung expression was found to be increased over untreated (Figure 6D). 




Figure 5: Matrices Derived from Nicotine-treated Fibroblasts Stimulates IL-1β 
Expression in Monocytic Cells 
(A) Lung fibroblasts (5x105 cells/6 well) were treated with nicotine (50 µg/ml) for 120 h. 
Human monocytic cells  (2x106 cells/6 well) expressing the human interleukin-1β gene 
promoter (described in methods) were overlaid atop of the fibroblast-derived extracellular 
matrix. Afterwards, expression of the IL-1β promoter was analyzed by luciferase assay. 
We found that collagen-containing matrices derived from nicotine-treated fibroblasts 
stimulated monocytic cells to express the pro-inflammatory cytokine IL-1β. Nicotine 
treated fibroblasts supplemented with the anti-oxidant NAC, significantly decreased IL-
1β promoter expression. (B) Nicotine induction of IL-1β was inhibited by anti-α2β1 
integrin antibodies. Experiments were repeated at least 3 times. Significance was 
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Figure 6 
 
Figure 6: Matrix-Stimulated IL-1β  Expression in Monocytic cells blocked by α7 
nAChR and MEK-1 Antagonist 
(A) Fibroblast extracellular matrices were isolated and IL-1β expression was determined 
as described in Figure 5. Nicotine-cultured fibroblast matrix IL-1β induction was 
inhibited by α7 nAChR antagonist MG 624 (10 µM) without affecting baseline 
expression. (B) Additionally, IL-1β induction was inhibited by MEK-1 inhibitor 
PD98059 (50 µM), which brought IL-1β expression below baseline. (C) IL-1β gene 
transcription was not changed on matrices derived from nicotine-treated α7 nAChR 
deficient primary lung fibroblasts over untreated. (D) Nicotine-treated and untreated 
C57BL/6 whole lung IL-1β gene transcription was examined by Real-time RT-PCR. 
Nicotine-treated lung expression was found increased over untreated. Experiments were 
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Nicotine stimulates the proliferation of lung fibroblasts through the MEK-1/Erk 
Pathway  
The above results suggest that nicotine, by acting on α7 nAChRs, stimulates the 
expression of collagen type I in lung fibroblasts. In turn, collagen-containing matrices 
derived from nicotine-treated fibroblasts may stimulate incoming monocytic cells to 
express IL-1β via activation of α2β1 integrins. Further work revealed potential 
proliferation amplifying pathways for these effects. For example, nicotine-stimulated 
proliferation of lung fibroblasts and was inhibited in cells silenced for α7 nAChR (Figure 
7A). Furthermore, we found that the mitogenic effects of nicotine were inhibited by 
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Figure 7: Nicotine Stimulates the Proliferation of Lung Fibroblasts via α7 nAChR-
mediated Induction of Erk 
(A) Lung fibroblasts were cultured for up to 72 h after transfection with control (Csi) or 
α7 nAChR siRNA (α7si). At the appropriate times, the experiment was halted and live 
cells counted. Nicotine stimulated cell proliferation, while α7 nAChR siRNA inhibited 
the nicotine-induced response. (B) Fibroblasts were cultured for up to 72 h with or 
without nicotine (50 µg/ml) in the presence or absence of PD98059 (MI, 50 µM), an 
inhibitor of MEK-1. Cell number was determined with the use of a Neubauer 
hemacytometer along with trypan blue stain. Cell viability was unchanged with 
treatment. Nicotine stimulated fibroblast proliferation at 48 h, though the effect was most 
noticeable at 72 h. The inhibitor PD98095 alone did not affect the proliferation of cells, 
but inhibited the stimulatory effect of nicotine. Experiments were repeated at least 3 






























    C          N        MI      N/MI   C          N         MI     N/MI C          N        MI      N/MI 




  24 
Nicotine Increases Collagen Expression in Lung  
C57BL/6J mice were exposed to nicotine in their drinking water (100 µg/ml) for 
90 days to test if nicotine’s mechanisms described above are relevant to the situation in 
vivo. As depicted in Figure 8A, we noted an increase in collagen type I mRNA 
expression in nicotine-treated wildtype mice, but the effect was absent in nicotine treated 
α7 deficient mice. In figure 8B, increased collagen type I protein was detected in the 
lungs of nicotine-treated mice. Consistent with data presented in Figure 7B regarding 
fibroblast proliferation, we observed induction of phosphorylated-Erk 1/2. Since TGF-β / 
Smad signaling has been implicated in lung remodeling, we tested the effects of nicotine 
on phosphorylated-Smad3 and it too was found to be increased, but total TGF-β was not.  
We then performed histological analysis of lung tissue harvested from untreated 
and nicotine-treated animals, and found increased collagen deposition which was most 
noticeable around airway and vascular structures (red arrows) in tissues submitted to both 
Masson’s tri-chrome and Sirius red staining (Figure 8C). The increase in collagen was 
confirmed through blinded scoring of unlabeled tissue slides by six graduate-level 
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Figure 8: Nicotine Stimulates Collagen Expression in Lung in vivo 
(A) The lungs of mice exposed to nicotine (100 µg/ml in the drinking water for 90 days) 
were isolated for RNA and wildtype showed increased collagen type I transcription. α7 
deficient mice (α7 KO) showed no increase in collagen type I transcription. (B) Protein 
analysis and showed an increase in collagen type I, p-Erk 1/2, and p-Smad protein 
expression when compared to control lungs. (C) Lungs were also inflated at standard 
pressure, fixed in formalin, paraffin-embedded, and sectioned (5 µm) for histological 
analysis. Lung sections were stained using Weigert's iron hematoxylin for 10 minutes, 
rinsed, treated with Biebrich scarlet-acid fuchsin solution for 10 minutes, washed and 
transferred to aniline blue stain for 30-60 minutes or stained with Sirius Red/Fast Green 
for 30 minutes. Arrows indicate increased collagen deposition (blue stain or Red stain) in 
animals exposed to nicotine. (D) The tri-chrome slides were blindly graded by 
histologists on a scale of 0-3 based on the intensity of collagen staining compared to a 
rubric (Figure 9). Experiments were repeated at least 3 times. Significance was assessed 
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Figure 9: Sample Images for Histology Blind Scoring 
Images provided an example for grading scales from 0-3 for scoring of histology slides 
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DISCUSSION 
Tobacco-related lung disease is an important problem worldwide. Chronic 
cigarette smoke exposure affects a large range of bodily functions, including innate and 
adaptive immunity. The prevalence of diseases associated with tobacco smoke include 
atherosclerosis, chronic obstructive pulmonary disease (COPD), Crohn’s disease, 
rheumatoid arthritis, and cancers of the lung, mouth, larynx, esophagus and bladder [32-
36].  
Several studies suggest that tobacco exposure promotes lung tissue remodeling 
through oxidant stress, inflammation, and the induction of matrix-degrading proteases, 
among other mechanisms. This is supported by animal studies showing that 
overexpression of matrix metalloproteinase (MMP)-1 promotes the development of 
emphysema in transgenic mice, while the lack of MMP-12 is protective [37, 38]. 
Furthermore, alterations in MMPs and other proteases have been detected in humans with 
tobacco-related lung disease [39]. Unfortunately, this information has not yet translated 
into the development of effective therapeutic strategies, although tetracyclines provide an 
opportunity with doxycycline inhibiting MMP activity and reducing bleomycin-induced 
injury in mice [40]. Here, we explore another mechanism of action - the induction of lung 
tissue remodeling through stimulation of extracellular matrix deposition. We 
hypothesized that nicotine, a major component of tobacco, is not only involved in 
tobacco addiction, but also stimulates lung fibroblasts to release matrix components that 
affect the relative composition of the lung matrix. 
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Consistent with this idea, we found that nicotine stimulates lung fibroblast 
expression and the release of collagen type I in a dose- and time-dependent manner. 
Previously, we have reported that nicotine stimulates the expression of fibronectin within 
the lung, a matrix glycoprotein implicated in lung injury and repair [23]. However, 
fibronectin matrices are often considered 'transitional’, whose deposition does not 
necessarily lead to irreversible changes in tissue architecture in the absence of other 
factors. The discovery that nicotine also stimulates the deposition of fibrillar collagens is 
important because it suggests that the effects of nicotine on matrix composition may be 
more permanent. Collagen is a major extracellular component, making up 25-35% of 
whole-body protein content [41]. Collagen type I is also highly expressed in injured lungs 
as demonstrated in acute lung injury, COPD, and chronic fibrotic lung disorders [42]. 
Additionally, collagen has been associated with extralobar pulmonary artery stiffening 
caused by chronic hypoxia [43], is thought to induce epithelial-to-mesenchymal transition 
in non-small cell lung cancer cell lines [44], and its fragments promote neutrophil 
chemotaxis [45].  
Epithelial-to-mesenchymal transition (EMT) is a fundamental biological process 
whereby epithelial cells differentiate to a mesenchymal phenotype. This change is 
characterized of increased migratory characteristics, loss of cell–cell adhesion, and 
reorganization of the actin cytoskeleton [46, 47]. EMT has been associated with cancer 
progression and metastasis, suggesting a transitional matrix might have the potential to 
directly affect cancer cells too. This potential needs to be further explored, which is 
discussed in the Future Work section below. 
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Considering the importance of the proposed mechanisms of action, we turned our 
attention to the pathways involved in stimulating collagen expression. We found that 
nicotine affected collagen expression in lung fibroblasts by acting on α7 nAChRs. α7 
nAChRs have been found to mediate the effects of nicotine in developing lungs [11, 48] 
and are implicated in the pathogenesis of lung cancer [49, 50]. More recently, 
morphological airway abnormalities and airflow limitations were detected in the 
offspring of nicotine-treated wildtype animals, but not in animals lacking α7 nAChRs. 
Interestingly, and reminiscent of our work, collagen was found to be upregulated around 
the airways of animals prenatally exposed to nicotine [48]. Based on the information 
presented here and the growing number of publications implicating α7 nAChRs in 
several disease states, it is reasonable to consider α7 nAChRs as promising targets for 
drug development to counteract the deleterious effects of tobacco. This is now possible 
considering that the technology to develop safe and effective agents that target nAChRs 
are currently available and in human use [51, 52]. Targeting this pathway will provide its 
own challenges, with nAChR stimulation inhibiting proper immune inflammatory 
response and unwanted neurological side effects. 
Another important finding was that nicotine also stimulated fibroblast 
proliferation, a process capable of further promoting tissue remodeling. This effect was 
also mediated via α7 nAChRs, as demonstrated by the lack of response in cells silenced 
for α7 nAChRs. Prior work has demonstrated that nicotine leads to Erk activation [23]. 
Consequently, we tested the role of Erk and found that a MEK-1/Erk inhibitor, PD98059, 
inhibited nicotine-induced fibroblast proliferation.  
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In our model, however, the deposition of new collagen fibrils was not associated 
with dramatic alterations in lung architecture. Research suggests these subtle changes in 
lung matrix composition caused by smoking may be linked with increases in the 
prevalence of some inflammatory diseases, including Parkinson’s diseases, ulcerative 
colitis, Alzheimer’s disease, and Sjogren’s syndrome [53-55]. We reason that newly 
deposited collagen fibrils do not affect the lung in the absence of other injurious stimuli, 
but instead, may influence immune cell function after injury, which could drive more 
extensive tissue remodeling.  
Alveolar macrophages and monocytes play a central role in the innate immune 
system [56]. Alveolar macrophages from smokers are functionally decreased and show a 
lower capacity to produce pro-inflammatory cytokines [57]. Immunosuppression is seen 
in animals treated with nicotine for several weeks [58]. Chronic exposure to nicotine in 
mice showed decreased clearance of Pseudomonas aeruginosa and developed COPD-like 
lesions [59].  
Our lab has previously shown that purified collagen type I can robustly activate 
monocytes [60]. In this report, we show that collagen-containing matrices derived from 
nicotine-treated fibroblasts are capable of activating human monocytic cells, stimulating 
their expression of the pro-inflammatory cytokine IL-1β. This is in line with our previous 
report on ethanol-treated fibroblast matrices stimulating significant IL-1β response [61]. 
As such, transitional remodeling could be accelerated in people who drink and smoke. 
Similar to alcohol though, nicotine-induced IL-1β gene transcription is significantly 
diminished in the presence of the anti-oxidant N-acetylcysteine (NAC). NAC is used as a 
supplement to help protect ethanol induced liver damage. This suggests a role of 
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oxidative stress in nicotine’s mechanism of action, which will be explored in future 
experiments. 
The increased IL-1β expression were inhibited by antibodies against α2β1, a 
collagen-binding integrin [62], or matrices derived from nicotine-treated α7 nAChR 
deficient primary lung fibroblasts when compared to controls (Figure 6). Integrins also 
control immune responses in T cells. For example, integrin-mediated binding to collagen 
provides a co-stimulatory signal for T cell activation [63], resulting in increased 
proliferation and secretion of pro-inflammatory cytokines such as Tumor Necrosis Factor 
(TNF-α) and Interferon-γ (IFN-γ) [64]. Thus, by promoting subtle alterations in matrix 
composition, nicotine may indirectly stimulate the exaggerated expression of pro-
inflammatory cytokines (e.g., IL-1β). Because nicotine has been previously shown to 
downregulate pro-inflammatory cytokines, increased IL-1β expression seen in our system 
is more likely to occur by immune cells recruited to the lung after injury. Thereby helping 
perpetuate inflammation, a process considered important in the pathogenesis of tobacco-
related lung disorders.  
Finally, to determine the potential relevance of our findings to the situation in 
vivo, we exposed mice to nicotine in their drinking water for 90 days. This model has 
been shown to increase nicotine levels in blood and tissue similar to those of heavy 
smokers without loss of body weight [65, 66]. Lower concentrations (40 ng/ml) of 
nicotine can be found in the blood of light to heavy smokers, while higher concentrations 
are deposited in body tissues [67]. Rowell and colleagues showed no significant decrease 
in fluid intake or weight gain at 100 µg/ml dose [65]. When examined, the harvested 
lungs showed increased collagen deposition predominating around airway and vascular 
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structures as determined by immunohistochemistry. Consistent with our in vitro findings, 
whole lung RNA showed increased collagen type I and IL-1β expression. Protein extracts 
of lung tissue also showed increased collagen type I and phosphorylation of Erk. We also 
detected increased phosphorylation of Smad3, a transcription factor known for mediating 
many of the pro-fibrotic effects of transforming growth factor β. However, total levels of 
transforming growth factor-β (TGF-β) protein levels and the lung microscopic pattern 
remained normal.  
These findings suggest that nicotine is capable of promoting fibronectin [23] and 
collagen type I (this report) deposition in the lung without affecting the organ’s overall 
architecture. We refer to this process as ‘transitional remodeling’.  
Elements of transitional remodeling have also been demonstrated in alcohol-
exposed rats and mice [29, 61], and in alcoholic subjects [68], in post-lung transplant 
recipients [69], and in aging mice [26]. However, the implications of transitional 
remodeling are unknown. It is presumed that if the stimulating agent is eliminated, a 
'normal' matrix is restored. In contrast, persistence of the transitional matrix may lead to 
ineffective repair after injury through the induction of pro-inflammatory agents directly 
or via the release of matrix fragments [70]. We and others have suggested that these 
changes may explain the increased incidence and mortality observed for acute lung injury 
in alcoholics [61, 68], the predisposition to lung cancer in smokers [19, 71], the 
development of rejection after lung transplantation [69], and the worse outcomes 
observed in elderly patients with pulmonary disorders [26]. However, until further studies 
are performed, these statements remain highly speculative. Nevertheless, the idea that 
transitional remodeling may precede processes such as COPD, acute lung injury and 
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pulmonary fibrosis, among other disorders, is tantalizing and testable. Furthermore, if 
found to be important, exploiting this process, through the development of technologies 
capable of detecting lung transitional remodeling in otherwise healthy individuals, may 
identify a subpopulation of subjects at risk for devastating pulmonary disorders. In 
summary, chronic nicotine exposure in mice results in transitional remodeling 
characterized by increased collagen type I expression/deposition in the lung, as well as 
activation of Erks and Smad3. In the absence of injury, this subtle change in matrix 
composition does not affect the overall lung architecture, but may promote exaggerated 
inflammatory (e.g., induction of IL-1β by immune cells) and repair (e.g., 
fibroproliferation) responses after injury (Figure 10). These events appear to be mediated 
via α7 nAChRs, which may represent promising targets for intervention should lung 
transitional remodeling be proven as a pre-disease susceptibility state that precedes (and 















Figure 10: Nicotine Induces Pro-inflammatory Transitional Matrix through α7 
nAChRs 
Chronic nicotine exposure in mice results in lung transitional remodeling, 
characterized by increased collagen type I expression/deposition in lung, as well as 
activation of Erks and Smad3. In the absence of injury, this subtle change in matrix 
composition does not affect the overall lung architecture, but promotes IL-1β expression 
by immune cells and repair (e.g., fibroproliferation) responses after injury. These events 
appear to be mediated via α7 nAChRs, which may represent promising targets for 
intervention should lung transitional remodeling be proven as a pre-disease susceptibility 
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CAVEATS AND WEAKNESSES 
One limitation of this study is the inability to test the effect of increased collagen 
in vivo. The monocyte’s response may not be as robust in vivo due to the complex 
environment of the lung. Additionally, the matrix laid on a plastic plate may not illicit the 
same immune response as a 3D matrix, however, Booth and colleagues recently 
published a technique to isolate decellularized lungs which would provide the tools to 
study this interaction in an ex vivo model [72]. Previous studies from our lab show that 
fibronectin does not accumulate within the matrix until after 72 hours of nicotine 
exposure, where significant increases in collagen type I expression and deposition are 
seen after 24 hours. The complete role of ‘transitional matrix’ remodeling is still unclear 
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FUTURE WORK 
Acellular 3D Lung Model 
Previous studies have reported the importance of nAChRs in prenatal lung 
development, with pulmonary structural and functional abnormalities being associated 
with collagen alterations [73, 74]. Wongtrakool reported changed lung branching 
morphology due to matrix expression [75]. So it is important to further characterize 
transitional lung remodeling and potential inflammatory signaling mechanisms. In hopes 
to create a more clinically relevant system, acellular lungs will be isolated from nicotine-
treated and untreated wildtype and α7 nAChR deficient C57BL/J mice for an ex vivo 
model [76].  
 
Mechanobiology of Nicotine-induced ‘Transitional Matrix’ 
In addition to protein compositions, recent research concludes that most 
eukaryotic cells can interact with physical properties of the ECM. Matrix stiffness has 
been shown to alter fibroblast morphology, proliferation, TGF-β signaling, and 
myofibroblast activation [77-80]. With α7 nAChR shown to play a critical role in 
nicotine’s stimulation of fibronectin and collagen deposition, it is conceivable that it 
plays an endogenous role of controlling deposited matrix stiffness. Using acellular lungs 
isolated from nicotine-treated and untreated mice, stiffness of transitional matrices will 
be analyzed by using peptide- based molecular probes capable of selectively 
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discriminating fibronectin fibers under different strain states [81]. Additionally, collagen 
plays an important role in matrix stiffness. Collagen post-translations will be determined, 
including fragmentation and crosslinking differences, using mass spectrometry in 
collaboration with Mike Merchant at University of Louisville [82]. 
 
Role in Lung Repair and Tissue Rejection 
We have shown that α7 nAChR is important for nicotine-induced ECM changes, 
but nAChRs might play a central role in lung repair. Lung transplants are characterized 
by uncontrollable remodeling, only giving patients an additional 5 years. Utilizing two 
well-published tissue remodeling murine models, heterotopic tracheal transplant and 
bleomycin induced injury [83, 84], α7 nAChR deficient and C56BL/J control mice will 
be utilized to test the role of α7 nAChRs in host response and tissue remodeling. 
Additionally, mice will be exposed to nicotine in their drinking water to test for any 
additive affects of nicotine to lung damage. 
 
α7 nAChR Activation by Oxidative Stress 
Several studies, including this one, suggest that tobacco exposure promotes lung 
tissue remodeling through oxidant stress, in addition to receptor binding. The trigger of 
this process is unknown, but we believe nicotinic acetylcholine receptors (nAChRs) 
might play an important role. A further area of focus would be to determine the effect of 
oxidative stress on nicotinic acetylcholine receptor activation. We have published 
findings that a modification of two cysteines in the α4 subunit within the α4 nAChR 
inhibits alcohol-induced cellular modifications [85]. Anti-oxidants and oxidants, N-
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acetylcysteine, paraquat, H2O2, and nicotine will be used on cells in vitro with modified 




In addition to fibrotic diseases, lung cancer is also highly associated with 
smoking. Another focus of future work will be exploring better treatments for lung 
cancer, hopefully providing better identification and treatment targets.  
Previous work and preliminary data suggests integrin receptors could play an 
important role in lung cancer growth and migration. While investigating the mechanisms 
leading to increased human lung cancer cell migration, we found that CRKL (a potential 
marker for cancer aggressiveness) overexpression induced the expression of α5, α9, β1 
integrins [86](Unpublished). This was associated with increased cell adhesion to 
fibronectin, collagen, and matrigel extracellular matrices. In addition, vimentin was 
inhibited in H358 cells silenced for β1 integrin or neutralized by anti-β1 or -α9 
antibodies. Haribabu Bodduluri’s laboratory (University of Louisville) has developed a 
murine highly metastatic cancer model using Lewis-Lung Carcinoma (LLC) cells, which 
has shown to increase cellular CRKL levels by microarray analysis (Unpublished).  
Considering all of our previous work was done in vitro, we plan to test the effects 
of CRKL expression levels in vivo. LLC cells have been permanently transfected with 
CRKL overexpression or shRNA vectors. Clones with the greatest overexpression or 
knockdown will be characterized by proliferation, migration, and invasion assays. 
Integrin expression will be investigated for potential therapeutic targets, such as an 
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integrin receptor inhibitor. Clones and wildtype LLC cells will be injected subcutaneous 
(5 x 105). In our hands, this model with wildtype LLC cells predictably produces a tumor 
within two weeks. We expect to see increased size, invasion, and metastasis in the CRKL 
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COPD Chronic Obstructive Pulmonary Disorder 
DMEM Dulbecco's Modified Eagle Medium 
EMT Epithelial-mesenchymal transition 
Erk Extracellular-signal-regulated kinase 
IL-1β Interleukin-1 beta  
nAChR Nicotinic Acetylcholine Receptor 
NAC N-acetylcysteine 
TGF-β Transforming Growth Factor-β 
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